Uric Acid Metabolism in Pre-hypertension and the Metabolic Syndrome

被引：27

作者：

Rizzo, Manfredi ^{[1
,2
,3
]}

Obradovic, Milan ^{[4
]}

Labudovic-Borovic, Milica ^{[5
]}

Nikolic, Dragana ^{[1
,4
]}

Montalto, Giuseppe ^{[1
]}

Rizvi, Ali A. ^{[3
]}

Mikhailidis, Dimitri P. ^{[6
]}

Isenovic, Esma R. ^{[4
]}

机构：

[1] Univ Palermo, Biomed Dept Internal Med & Med Specialties, I-90133 Palermo, Italy

[2] Euro Mediterranean Inst Sci & Technol, Palermo, Italy

[3] Univ S Carolina, Sch Med, Div Endocrinol Diabet & Metab, Columbia, SC USA

[4] Univ Belgrade, Inst Vinca, Lab Radiobiol & Mol Genet, Belgrade 11000, Serbia

[5] Univ Belgrade, Fac Med, Inst Histol & Embryol Aleksandar D Kostic, Belgrade 11000, Serbia

[6] UCL, Sch Med, Vascu Dis Prevent Clin, Dept Clin Biochem, London W1N 8AA, England

来源：

CURRENT VASCULAR PHARMACOLOGY | 2014年 / 12卷 / 04期

关键词：

Cardiovascular risk; metabolic syndrome; metabolism; pre-hypertension; uric acid; CORONARY-HEART-DISEASE; SERUM RESISTIN LEVELS; LIPOPROTEIN LDL SUBCLASSES; TYPE-2; DIABETIC-PATIENTS; POST-HOC ANALYSIS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; LOW-DENSITY; ARTERY-DISEASE; RISK-FACTOR;

D O I：

10.2174/1570161111999131205160756

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

In humans uric acid (UA) is the end product of degradation of purines. The handling of UA by the renal system is a complex process which is not fully understood. To date, several urate transporters in the renal proximal tubule have been identified. Among them, urate transporter 1 (URAT1) and a glucose transporter 9 (GLUT9) are considered of greater importance, as potential targets for treatment of hyperuricemia and the potential associated cardio-metabolic risk. Therefore, the recognition of the metabolic pathway of UA and elucidation of occurrence of hyperuricemia may provide important insights about the relationship between UA, pre-hypertension (preHT) and the metabolic syndrome (MetS). We also review the available clinical studies in this field, including experimental studies dealing with the mechanisms of UA transport via different transporters, as well as current treatment options for hyperuricemia in patients with MetS, preHT or cardiovascular risk factors.

引用

页码：572 / 585

页数：14

共 50 条

[1] The management of pre-hypertension and metabolic syndrome
Francesco, Pollice
[J]. INTERNATIONAL CONFERENCE ON PRE-HYPERTENSION AND CARDIO METABOLIC SYNDROME (PREHT), 2011, : 75 - 78
[2] Pre-hypertension and metabolic syndrome in a newfoundland population
Turton, P.
Fodor, J. G.
Helis, E.
Chockalingam, A.
Cifkova, R.
[J]. EUROPEAN HEART JOURNAL, 2008, 29 : 233 - 233
[3] Risk factors of subjects with pre-hypertension in metabolic syndrome
Lin, JD
Chiou, WK
Chang, HY
Liu, FH
Weng, HF
Liu, TH
[J]. DIABETOLOGIA, 2005, 48 : A374 - A374
[4] Association between Serum Uric Acid and Pre-hypertension and Hypertension among Chinese Adults
Zhu, Lijun
Zhang, Xiaoyu
Fang, Zhengmei
Jin, Yuelong
Chang, Weiwei
Chen, Yan
Yao, Yingshui
[J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 116 (06) : 1072 - 1077
[5] Metabolic syndrome and new category 'pre-hypertension' in a Japanese population
Kanauchi, M
Kanauchi, K
Hashimoto, T
Saito, Y
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) : 1365 - 1370
[6] Pre-hypertension
Shvartzman, P.
[J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2007, 9 (05): : 416 - 416
[7] Role of uric acid in hypertension, renal disease, and metabolic syndrome
Heinig, Marcelo
Johnson, Richard J.
[J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2006, 73 (12) : 1059 - 1064
[8] Is Metabolic Syndrome Related to Uric Acid Metabolism in Gout Patients?
Harris, Donald J.
[J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (08) : 412 - 412
[9] Uric Acid Metabolism in Patients with Primary Gout and the Metabolic Syndrome
Fraile, J. M.
Puig, J. G.
Torres, Rosa J.
de Miguel, Eugenio
Martinez, Pedro
Vazquez, J. J.
[J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2010, 29 (4-6): : 330 - 334
[10] Progression of Pre-hypertension
Giles, Thomas D.
[J]. CURRENT HYPERTENSION REPORTS, 2011, 13 (04) : 262 - 264

← 1 2 3 4 5 →